Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rotterdam

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 6, 2001
Nutrient intake and risk of subtypes of esophageal and gastric cancerS T Mayne, H A Risch, R Dubrow, et al.
Journal of the National Cancer Institute|September 18, 1997
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardiaM D Gammon, J B Schoenberg, H Ahsan, et al.
Journal of the National Cancer Institute|February 5, 1998
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardiaW H Chow, W J Blot, T L Vaughan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 6, 1998
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancerD C Farrow, T L Vaughan, P D Hansten, et al.
International Journal of Cancer|June 8, 2001
Family history of cancer and risk of esophageal and gastric cancers in the United StatesP K Dhillon, D C Farrow, T L Vaughan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 30, 1998
Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal refluxT L Vaughan, D C Farrow, P D Hansten, et al.
Cancer Causes & Control : CCC|April 27, 2000
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancerD C Farrow, T L Vaughan, C Sweeney, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 6, 2001
Nutrient intake and risk of subtypes of esophageal and gastric cancerS T Mayne, H A Risch, R Dubrow, et al.
Journal of the National Cancer Institute|September 18, 1997
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardiaM D Gammon, J B Schoenberg, H Ahsan, et al.
Journal of the National Cancer Institute|February 5, 1998
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardiaW H Chow, W J Blot, T L Vaughan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 6, 1998
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancerD C Farrow, T L Vaughan, P D Hansten, et al.
International Journal of Cancer|June 8, 2001
Family history of cancer and risk of esophageal and gastric cancers in the United StatesP K Dhillon, D C Farrow, T L Vaughan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 30, 1998
Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal refluxT L Vaughan, D C Farrow, P D Hansten, et al.
Cancer Causes & Control : CCC|April 27, 2000
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancerD C Farrow, T L Vaughan, C Sweeney, et al.
Pageof 6